Subacute sclerosing panencephalitis (SSPE) is a rare, progressive neurological disorder that typically occurs 7 to 10 years after a person has measles. It is caused by a persistent infection of the central nervous system with the measles virus. The clinical importance of SSPE lies in its severe neurological decline, leading to cognitive impairment, seizures, and ultimately death. Accurate diagnosis and documentation using ICD-10 Code A81.1 are essential for effective medical billing, public health reporting, and ensuring appropriate patient management.
ICD-10 Code A81.1 represents Subacute sclerosing panencephalitis, a progressive neurological disorder that arises as a complication of measles infection. This code should be used in clinical documentation and billing when diagnosing patients who exhibit neurological symptoms following a history of measles, ensuring proper identification of the condition for treatment and reimbursement purposes.
Subacute sclerosing panencephalitis is caused by a persistent infection of the central nervous system with the measles virus, leading to progressive neurological deterioration. The condition typically manifests several years after the initial measles infection, necessitating prompt medical attention to manage symptoms and improve quality of life.
ICD-10 Code A81.1 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to Subacute sclerosing panencephalitis. This code is relevant in both acute and chronic care settings, facilitating comprehensive patient management and accurate billing.
In SOAP notes, ICD-10 Code A81.1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Subacute sclerosing panencephalitis. This ensures continuity of care, supports appropriate billing practices, and meets EHR documentation standards.
Subacute sclerosing panencephalitis requires urgent medical intervention, often necessitating hospitalization for comprehensive care. Treatment focuses on managing symptoms and providing supportive care.
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code A81.1 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.
CPT Code | Description |
---|---|
99214 | Established patient office visit, moderate complexity. |
96372 | Therapeutic, prophylactic, or diagnostic injection. |
95816 | Electroencephalogram (EEG) monitoring. |
70553 | MRI brain with and without contrast. |
Common Questions About Using ICD-10 Code A81.1 for Subacute sclerosing panencephalitis
What are the common symptoms of Subacute sclerosing panencephalitis?
Common symptoms include cognitive decline, seizures, ataxia, and visual disturbances. These symptoms typically develop several years after a measles infection.
How is Subacute sclerosing panencephalitis diagnosed?
Diagnosis is based on clinical history, neurological examination, and imaging studies such as MRI or EEG to assess brain function and structure.
Is Subacute sclerosing panencephalitis contagious?
No, Subacute sclerosing panencephalitis is not contagious. It is a complication of a previous measles infection and does not spread from person to person.
What is the prognosis for patients with Subacute sclerosing panencephalitis?
The prognosis is generally poor, with progressive neurological decline leading to severe disability and often death within a few years of diagnosis.
Clinical Notes
SOAP notes
DAP notes
AI medical notes